Volume 28, Issue 19
Research Article

The estimation of average hazard ratios by weighted Cox regression

Michael Schemper

Corresponding Author

E-mail address: michael.schemper@meduniwien.ac.at

Section of Clinical Biometrics, Department for Medical Statistics and Informatics, Medical University of Vienna, Spitalgasse 23, A‐1090 Vienna, Austria

Section of Clinical Biometrics, Department for Medical Statistics and Informatics, Medical University of Vienna, Spitalgasse 23, A‐1090 Vienna, AustriaSearch for more papers by this author
Samo Wakounig

Section of Clinical Biometrics, Department for Medical Statistics and Informatics, Medical University of Vienna, Spitalgasse 23, A‐1090 Vienna, Austria

Search for more papers by this author
Georg Heinze

Section of Clinical Biometrics, Department for Medical Statistics and Informatics, Medical University of Vienna, Spitalgasse 23, A‐1090 Vienna, Austria

Search for more papers by this author
First published: 26 May 2009
Citations: 95

Abstract

Often the effect of at least one of the prognostic factors in a Cox regression model changes over time, which violates the proportional hazards assumption of this model. As a consequence, the average hazard ratio for such a prognostic factor is under‐ or overestimated. While there are several methods to appropriately cope with non‐proportional hazards, in particular by including parameters for time‐dependent effects, weighted estimation in Cox regression is a parsimonious alternative without additional parameters. The methodology, which extends the weighted k‐sample logrank tests of the Tarone‐Ware scheme to models with multiple, binary and continuous covariates, has been introduced in the nineties of the last century and is further developed and re‐evaluated in this contribution. The notion of an average hazard ratio is defined and its connection to the effect size measure P(X<Y) is emphasized. The suggested approach accomplishes estimation of intuitively interpretable average hazard ratios and provides tools for inference. A Monte Carlo study confirms the satisfactory performance. Advantages of the approach are exemplified by comparing standard and weighted analyses of an international lung cancer study. SAS and R programs facilitate application. Copyright © 2009 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 95

  • Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era, Journal of Geriatric Oncology, 10.1016/j.jgo.2019.12.013, (2020).
  • Inverse probability of treatment analysis of open VS Endovascular repair in ruptured infrarenal aortic aneurysm – Cohort study, International Journal of Surgery, 10.1016/j.ijsu.2020.05.090, (2020).
  • Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality, Journal of the American College of Cardiology, 10.1016/j.jacc.2020.04.038, 75, 23, (2921-2930), (2020).
  • Incorporating sampling weights into robust estimation of Cox proportional hazards regression model, with illustration in the Multi-Ethnic Study of Atherosclerosis, BMC Medical Research Methodology, 10.1186/s12874-020-00945-9, 20, 1, (2020).
  • Quantifying treatment differences in confirmatory trials under non-proportional hazards, Journal of Applied Statistics, 10.1080/02664763.2020.1815673, (1), (2020).
  • The Beneficial Effects Of Medicare Advantage Special Needs Plans For Patients With End-Stage Renal Disease, Health Affairs, 10.1377/hlthaff.2019.01793, 39, 9, (1486), (2020).
  • CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis, The Journal of Clinical Endocrinology & Metabolism, 10.1210/clinem/dgaa527, 105, 11, (2020).
  • Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial, The Lancet Oncology, 10.1016/S1470-2045(20)30541-6, (2020).
  • Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996–2014, Cancer Epidemiology, 10.1016/j.canep.2020.101825, 69, (101825), (2020).
  • Association Between Prescribed Hypnotics in Infants and Toddlers and Later ADHD: A Large Cohort Study from Norway, Child Psychiatry & Human Development, 10.1007/s10578-020-01039-9, (2020).
  • Five-year survival analysis and predictors of death in HIV-positive serology patients attending the Military Hospital of Nampula, Mozambique, AIDS Care, 10.1080/09540121.2020.1761938, (1-9), (2020).
  • On Weighted Log-Rank Combination Tests and Companion Cox Model Estimators, Statistics in Biosciences, 10.1007/s12561-020-09276-1, (2020).
  • An Assessment of the Treatment Effect in Treatment of Physician Choice Trials, Statistics in Biopharmaceutical Research, 10.1080/19466315.2020.1801496, (1-30), (2020).
  • Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology, Clinical Trials, 10.1177/1740774520940256, (174077452094025), (2020).
  • Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT, Journal of Clinical Oncology, 10.1200/JCO.19.00396, (JCO.19.00396), (2020).
  • A multistate model for early decision‐making in oncology, Biometrical Journal, 10.1002/bimj.201800250, 62, 3, (550-567), (2019).
  • Combined test versus logrank/Cox test in 50 randomised trials, Trials, 10.1186/s13063-019-3251-5, 20, 1, (2019).
  • Cox regression increases power to detect genotype-phenotype associations in genomic studies using the electronic health record, BMC Genomics, 10.1186/s12864-019-6192-1, 20, 1, (2019).
  • Subgroup analysis of treatment effects for misclassified biomarkers with time‐to‐event data, Journal of the Royal Statistical Society: Series C (Applied Statistics), 10.1111/rssc.12364, 68, 5, (1447-1463), (2019).
  • Prognostically Significant Myocardial Injury in Patients Undergoing Transcatheter Aortic Valve Replacement, Journal of the American Heart Association, 10.1161/JAHA.118.011889, 8, 14, (2019).
  • Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor, World Journal of Urology, 10.1007/s00345-019-02754-2, (2019).
  • Quantifying time-varying cause-specific hazard and subdistribution hazard ratios with competing risks data, Clinical Trials, 10.1177/1740774519852708, (174077451985270), (2019).
  • Return to work after primary total hip arthroplasty: a nationwide cohort study, Acta Orthopaedica, 10.1080/17453674.2019.1591081, (1-9), (2019).
  • Improving testing and description of treatment effect in clinical trials with survival outcomes, Statistics in Medicine, 10.1002/sim.7676, 38, 4, (530-544), (2018).
  • On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies, Pharmaceutical Statistics, 10.1002/pst.1915, 18, 2, (166-183), (2018).
  • Determining risk factors that increase hospitalizations in patients with systemic lupus erythematosus, Lupus, 10.1177/0961203318770534, 27, 8, (1321-1328), (2018).
  • Assessing the effect of a partly unobserved, exogenous, binary time-dependent covariate on survival probabilities using generalised pseudo-values, BMC Medical Research Methodology, 10.1186/s12874-017-0430-5, 18, 1, (2018).
  • A mechanistic classification of clinical phenotypes in neuroblastoma, Science, 10.1126/science.aat6768, 362, 6419, (1165-1170), (2018).
  • Nonparametric adaptive enrichment designs using categorical surrogate data, Statistics in Medicine, 10.1002/sim.7936, 37, 29, (4507-4524), (2018).
  • Causal estimands and confidence intervals associated with Wilcoxon‐Mann‐Whitney tests in randomized experiments, Statistics in Medicine, 10.1002/sim.7799, 37, 20, (2923-2937), (2018).
  • A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes, Clinical Trials, 10.1177/1740774518769865, 15, 3, (305-312), (2018).
  • Estimation of delay time in survival data with delayed treatment effect, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2018.1534857, (1-15), (2018).
  • Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design framework, Journal of Biopharmaceutical Statistics, 10.1080/10543406.2017.1372775, 28, 4, (589-611), (2017).
  • Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma, Oncotarget, 10.18632/oncotarget.16965, 8, 23, (37423-37434), (2017).
  • Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus, Scientific Reports, 10.1038/srep40627, 7, 1, (2017).
  • Incidence and Time Course for Developing Heart Failure With High-Burden Right Ventricular Pacing, Circulation: Cardiovascular Quality and Outcomes, 10.1161/CIRCOUTCOMES.117.003564, 10, 6, (2017).
  • On hazard ratio estimators by proportional hazards models in matched-pair cohort studies, Emerging Themes in Epidemiology, 10.1186/s12982-017-0060-8, 14, 1, (2017).
  • The Single-Stage Design, Planning and Analyzing Clinical Trials with Composite Endpoints, 10.1007/978-3-319-73770-6_5, (31-51), (2017).
  • Use of the concordance index for predictors of censored survival data, Statistical Methods in Medical Research, 10.1177/0962280216680245, 27, 8, (2359-2373), (2016).
  • Goodness‐of‐fit test for monotone proportional subdistribution hazards assumptions based on weighted residuals, Statistics in Medicine, 10.1002/sim.7153, 36, 2, (362-377), (2016).
  • Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial, Breast Cancer Research and Treatment, 10.1007/s10549-016-3727-x, 156, 1, (97-107), (2016).
  • Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated, BMC Medical Research Methodology, 10.1186/s12874-016-0110-x, 16, 1, (2016).
  • Nonmedical Opioid Pain Relievers and All-Cause Mortality: A 27-Year Follow-Up From the Epidemiologic Catchment Area Study, American Journal of Public Health, 10.2105/AJPH.2015.302961, 106, 3, (509-516), (2016).
  • A practical divergence measure for survival distributions that can be estimated from Kaplan–Meier curves, Statistics in Medicine, 10.1002/sim.6868, 35, 14, (2406-2421), (2016).
  • Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults, Leukemia, 10.1038/leu.2015.239, 30, 5, (1177-1180), (2015).
  • Investment behavior and status quo bias of conventional and organic hog farmers: An experimental approach, Renewable Agriculture and Food Systems, 10.1017/S1742170515000265, 31, 4, (318-329), (2015).
  • On the interpretation of risk and rate advancement periods, International Journal of Epidemiology, 10.1093/ije/dyv320, 45, 1, (278-284), (2015).
  • Neighborhood Latino ethnic density and mortality among HIV-positive Latinos by birth country/region, Florida, 2005–2008, Ethnicity & Health, 10.1080/13557858.2015.1061104, 21, 3, (268-283), (2015).
  • Misspecified poisson regression models for large‐scale registry data: inference for ‘large n and small p’, Statistics in Medicine, 10.1002/sim.6755, 35, 7, (1117-1129), (2015).
  • Impact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 Years, The Journal of Clinical Endocrinology & Metabolism, 10.1210/jc.2014-3039, 100, 1, (115-121), (2015).
  • Effects of immune challenge on the oviposition strategy of a noctuid moth, Journal of Evolutionary Biology, 10.1111/jeb.12677, 28, 8, (1568-1577), (2015).
  • Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy, Medicine, 10.1097/MD.0000000000001861, 94, 42, (e1861), (2015).
  • Editorial: To the memory of John P. Klein, Lifetime Data Analysis, 10.1007/s10985-015-9320-5, 21, 2, (157-159), (2015).
  • High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell–Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia, Biology of Blood and Marrow Transplantation, 10.1016/j.bbmt.2015.07.029, 21, 11, (1985-1993), (2015).
  • Assessing potentially time‐dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial, Statistics in Medicine, 10.1002/sim.6453, 34, 11, (1801-1817), (2015).
  • Analysis of Time to Event Outcomes in Randomized Controlled Trials by Generalized Additive Models, PLOS ONE, 10.1371/journal.pone.0123784, 10, 4, (e0123784), (2015).
  • Standardized Mortality Ratio for Evaluating Center-Specific Mortality: Assessment and Alternative, Statistics in Biosciences, 10.1007/s12561-014-9119-z, 7, 2, (296-321), (2014).
  • Quantifying the average of the time-varying hazard ratio via a class of transformations, Lifetime Data Analysis, 10.1007/s10985-014-9301-0, 21, 2, (259-279), (2014).
  • Circulating miRNA markers show promise as new prognosticators for multiple myeloma, Leukemia, 10.1038/leu.2014.155, 28, 9, (1922-1926), (2014).
  • An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect, Trials, 10.1186/1745-6215-15-314, 15, 1, (314), (2014).
  • Estimation of Main Effect When Covariates Have Non-Proportional Hazards, Communications in Statistics - Simulation and Computation, 10.1080/03610918.2012.744043, 43, 7, (1760-1770), (2014).
  • Incidence of Type 2 diabetes among occupational classes in Sweden: a 35‐year follow‐up cohort study in middle‐aged men, Diabetic Medicine, 10.1111/dme.12405, 31, 6, (674-680), (2014).
  • Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients, Cancer Medicine, 10.1002/cam4.264, 3, 4, (998-1009), (2014).
  • No evidence of benefit from antibiotic lock therapy in pediatric oncology patients with central line‐related bloodstream infection: Results of a retrospective matched cohort study and review of the literature, Pediatric Blood & Cancer, 10.1002/pbc.25101, 61, 10, (1811-1815), (2014).
  • Estimation of Causal Odds of Concordance using the Aalen Additive Model, Scandinavian Journal of Statistics, 10.1002/sjos.12004, 41, 1, (141-151), (2013).
  • Life form influences survivorship patterns for 109 herbaceous perennials from six semi‐arid ecosystems, Journal of Vegetation Science, 10.1111/jvs.12106, 25, 4, (947-954), (2013).
  • An efficient and robust method for analyzing population pharmacokinetic data in genome‐wide pharmacogenomic studies: a generalized estimating equation approach, Statistics in Medicine, 10.1002/sim.5895, 32, 27, (4838-4858), (2013).
  • Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome, BMC Medical Research Methodology, 10.1186/1471-2288-13-152, 13, 1, (2013).
  • Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival, Value in Health, 10.1016/j.jval.2013.03.1630, 16, 5, (760-768), (2013).
  • Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e328357bb04, 14, 6, (421-429), (2013).
  • Landscape configuration influences gap-crossing decisions of northern flying squirrel (Glaucomys sabrinus), Biological Conservation, 10.1016/j.biocon.2013.10.008, 168, (176-183), (2013).
  • Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial, The Lancet Oncology, 10.1016/S1470-2045(12)70560-0, 14, 2, (149-158), (2013).
  • Estimation of odds of concordance based on the Aalen additive model, Lifetime Data Analysis, 10.1007/s10985-012-9234-4, 19, 1, (100-116), (2012).
  • Bayesian modeling of time‐dependent vulnerability to environmental hazards: an example using autism and pesticide data, Statistics in Medicine, 10.1002/sim.5600, 32, 13, (2308-2319), (2012).
  • Low testosterone levels as an independent predictor of mortality in men with chronic liver disease, Clinical Endocrinology, 10.1111/j.1365-2265.2012.04347.x, 77, 2, (323-328), (2012).
  • A Semiparametric Change-Point Regression Model for Longitudinal Observations, Journal of the American Statistical Association, 10.1080/01621459.2012.712425, 107, 500, (1625-1637), (2012).
  • Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes, Leukemia Research, 10.1016/j.leukres.2011.09.007, 36, 2, (132-139), (2012).
  • Comparison of absolute benefits of anticancer therapies determined by snapshot and area methods, Annals of Oncology, 10.1093/annonc/mds174, 23, 11, (2977-2982), (2012).
  • Distribution‐free inference on contrasts of arbitrary summary measures of survival, Statistics in Medicine, 10.1002/sim.4505, 31, 16, (1722-1737), (2012).
  • Non-parametric estimation of relative risk in survival and associated tests, Statistical Methods in Medical Research, 10.1177/0962280211431022, 24, 6, (856-870), (2011).
  • Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?, British Journal of Cancer, 10.1038/bjc.2011.559, 106, 2, (297-306), (2011).
  • Comparison of procedures to assess non‐linear and time‐varying effects in multivariable models for survival data, Biometrical Journal, 10.1002/bimj.201000159, 53, 2, (308-331), (2011).
  • Different competing risks models applied to data from the Australian Orthopaedic Association National Joint Replacement Registry, Acta Orthopaedica, 10.3109/17453674.2011.618918, 82, 5, (513-520), (2011).
  • Statistical analysis of arthroplasty data, Acta Orthopaedica, 10.3109/17453674.2011.588863, 82, 3, (258-267), (2011).
  • Independent effects of connectivity predict homing success by northern flying squirrel in a forest mosaic, Landscape Ecology, 10.1007/s10980-011-9595-1, 26, 5, (709-721), (2011).
  • A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database, International Journal of Cardiology, 10.1016/j.ijcard.2010.07.008, 152, 1, (70-77), (2011).
  • Robust estimation for the Cox regression model based on trimming, Biometrical Journal, 10.1002/bimj.201100008, 53, 6, (956-973), (2011).
  • The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt, Statistics in Medicine, 10.1002/sim.4274, 30, 19, (2409-2421), (2011).
  • An overview of robust methods in medical research, Statistical Methods in Medical Research, 10.1177/0962280210385865, 21, 2, (111-133), (2010).
  • Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time‐dependent hazards and delayed entry, Statistics in Medicine, 10.1002/sim.4123, 30, 6, (654-665), (2010).
  • Natural History of Very Severe Aortic Stenosis, Circulation, 10.1161/CIRCULATIONAHA.109.894170, 121, 1, (151-156), (2010).
  • Statistical analysis of arthroplasty register data, Acta Orthopaedica, 10.3109/17453671003587168, 81, 1, (10-14), (2010).
  • Gene selection in microarray survival studies under possibly non-proportional hazards, Bioinformatics, 10.1093/bioinformatics/btq035, 26, 6, (784-790), (2010).
  • Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified, Statistics in Medicine, 10.1002/sim.3786, 29, 7‐8, (875-884), (2010).
  • Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology, Pharmaceutical Statistics, 10.1002/pst.2062, 0, 0, (undefined).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.